EXPERT REV CLIN PHAR 润色咨询

Expert Review of Clinical Pharmacology

出版年份：暂无数据 年文章数：755 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：2.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=846709, encodeId=3921846e0908, content=药学好期刊挺多的，这个只能说太不起眼了所以没什么人投稿吧，其实审稿人也很nice. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Aug 28 16:33:56 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106105, encodeId=0f9011061056f, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106106, encodeId=29bd110610697, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2018-08-28 ms6597719114830456

    药学好期刊挺多的，这个只能说太不起眼了所以没什么人投稿吧，其实审稿人也很nice.

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=846709, encodeId=3921846e0908, content=药学好期刊挺多的，这个只能说太不起眼了所以没什么人投稿吧，其实审稿人也很nice. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Aug 28 16:33:56 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106105, encodeId=0f9011061056f, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106106, encodeId=29bd110610697, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    researcharticle是什么意思？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=846709, encodeId=3921846e0908, content=药学好期刊挺多的，这个只能说太不起眼了所以没什么人投稿吧，其实审稿人也很nice. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=769c5414093, createdName=ms6597719114830456, createdTime=Tue Aug 28 16:33:56 CST 2018, time=2018-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106105, encodeId=0f9011061056f, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106106, encodeId=29bd110610697, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    什么是letter?

    1

    展开1条回复
共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分